Four percent of firms that offer health benefits, and 9% of firms that do not offer health benefits, offer funds to one or more of their employees to purchase non-group coverage in 2025 [Figure 2.9]
Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach
If you identify as a non-patient, it tells you to email support
EPS on a non-GAAP basis grew 156% to $8.55
Optimizing your tirzepatide results: practical strategies Switching medications alone is not enough
And from a homeopathic perspective, when you remove a growth, you stimulate the vital force to greater activity